Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for Tourette Syndrome
Megadott ok: Inability to recruit participants
A legfontosabb adatok
- Fázis
- 1. fázis
A vizsgálat adatai
- Ki végzi
- The Foundation for Orthopaedics and Regenerative Medicine
- Azonosító
- NCT05158439
- A regiszteradat frissítve
- 2026. október 16.
- Eredeti leírás
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells for the treatment of Tourette SyndromeA teljes eredeti leírásKevesebb
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Tourette Syndrome
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells for the treatment of Tourette Syndrome
Bevonási feltételek: Diagnosis of Tourette Syndrome; Understanding and willingness to sign a written informed consent document.
Kizáró feltételek: Continued drug abuse; Previous organ transplant; Active infection; Active cancer; Chronic multisystem organ failure; Medical condition that would (based on the opinion of the investigator) compromise patient's safety; Hypersensitivity to sulfur; Clinically significant Abnormalities on pre-treatment laboratory evaluation; Pregnancy; Pre-menopausal women not using contraception.